• 6 months ago
Artificial intelligence (AI) is on the cusp of transforming nearly every single industry. When it comes to healthcare, several trends have emerged.

As doctors and scientists continue to innovate, the market for AI in healthcare is expanding. The AI healthcare market appears poised for growth, with a market size of $22 billion in 2023 – a number that's expected to accelerate at a CAGR of 36.4% from 2024-2030. The market for AI in healthcare is expected to reach $187.95 billion by 2030, demonstrating the transformative shift it's brought to the healthcare industry.

AI-focused healthcare companies are driving this progress.

Category

🗞
News
Transcript
00:00 Artificial intelligence, or AI, is revolutionizing industries across the board, and healthcare
00:07 is no exception.
00:09 Here are three key trends in healthcare guided by AI, along with the companies driving these
00:14 innovations.
00:15 First, the AI healthcare market is expanding rapidly, with a projected growth to $187.95
00:21 billion by 2030.
00:23 This transformative shift is being led by innovative companies harnessing the power
00:27 of AI.
00:28 One such company is Moderna, which is leveraging AI to drive innovation in drug development.
00:34 By partnering with OpenAI, Moderna aims to introduce 15 new products by 2029, streamlining
00:40 processes and accelerating time to market.
00:43 Already, 65% of Moderna employees are active AI users, utilizing the technology to enhance
00:49 efficiency and scalability throughout the organization.
00:52 Secondly, AI is facilitating targeted treatments, particularly in precision medicine.
00:59 Companies like Johnson & Johnson are using AI to identify suitable patients for clinical
01:04 trials, expanding access to potentially life-saving treatments.
01:08 Lastly, AI is increasing access to healthcare, with companies like CardioDiagnostics developing
01:13 AI-powered tests for conditions like coronary heart disease.
01:17 These tests offer scalable, non-invasive alternatives, particularly beneficial for underserved communities.
01:24 The company is behind PrecisionCHD, the first integrated genetic/epigenetic test for the
01:29 detection of coronary heart disease (CHD), the most common type of heart disease and
01:35 the cause of most heart attacks.
01:37 With the introduction of PrecisionCHD, clinicians are armed with a powerful, scalable, and non-invasive
01:44 alternative that comes in the form of a blood-based test that uses AI, along with personalized
01:49 genetic and epigenetic information, to sensitively detect the presence of CHD and use the information
01:56 for more personalized patient management.
01:58 As AI continues to evolve, it's clear that its impact on healthcare will be profound,
02:03 driving innovation, targeting treatments, and increasing access for all.
02:08 With companies at the forefront of this revolution, the future of healthcare looks brighter than
02:12 ever.

Recommended